Featured Research

from universities, journals, and other organizations

Reawakening neurons: Researchers find an epigenetic culprit in memory decline

Date:
February 29, 2012
Source:
Howard Hughes Medical Institute
Summary:
In a mouse model of Alzheimer's disease, memory problems stem from an overactive enzyme that shuts off genes related to neuron communication. Researchers genetically blocked the enzyme HDAC2, and 'reawakened' some of the neurons -- restoring the animals' cognitive function.

In a mouse model of Alzheimer's disease, memory problems stem from an overactive enzyme that shuts off genes related to neuron communication, a new study says.

When researchers genetically blocked the enzyme, called HDAC2, they 'reawakened' some of the neurons and restored the animals' cognitive function. The results, published February 29, 2012, in the journal Nature, suggest that drugs that inhibit this particular enzyme would make good treatments for some of the most devastating effects of the incurable neurodegenerative disease.

"It's going to be very important to develop selective chemical inhibitors against HDAC2," says Howard Hughes Medical Institute investigator Li-Huei Tsai, whose team at the Massachusetts Institute of Technology performed the experiments. "If we could delay the cognitive decline by a certain period of time, even six months or a year, that would be very significant."

In every cell, DNA wraps itself around proteins called histones. Chemical groups such as methyl and acetyl can bind to histones and affect DNA expression. HDAC2 is a histone deacetylase, an enzyme that removes acetyl groups from the histone, effectively turning off nearby genes.

In 2007, Tsai's group reported in Nature that this so-called epigenetic change can contribute to cognitive decline. They used a strain of mutant mice developed in her lab called CK-p25, which shows a profound loss of neurons and synapses, the junctions between neurons. The animals also carry the amyloid-beta plaques thought to cause Alzheimer's disease and show impaired learning and memory. When Tsai's team gave the mice drugs that block all HDACs, the animals sprouted more synapses and showed better memory function.

There are 19 known HDACs. In 2009, the researchers found that one of these, HDAC2, can cause a loss of synapses and memory function in normal mice.

The new study pulls from both of these previous findings, investigating HDAC2's affect on CK-p25 mice.

The researchers showed that the mutant animals have an elevated level of HDAC2 in two regions known to be affected in neurodegenerative disease: the hippocampus, important for learning and memory, and part of the temporal lobe called the entorhinal cortex. In these regions, the researchers also found that HDAC2 binds to a host of memory genes and dampens their expression.

Tsai's team then used a technique called RNA interference to silence the expression of HDAC2 in neurons in the hippocampus. Four weeks later, they found a dramatic increase in synaptic density. What's more, when given two different memory tests, the treated animals were indistinguishable from normal controls.

Blocking HDAC2 expression did not change the number of dying neurons. Still, the findings suggest that memory can be improved even in later stages of the disease, Tsai says.

"The neurons that are still alive are essentially zombies: they're not really functioning properly because of the epigenetic blockade," Tsai says. "What we're showing is that, if we can get some of those neurons to wake up, we can get cognitive function to recover to a certain extent."

Using hippocampal neurons grown in culture, Tsai also uncovered a potential mechanism that raises the level of HDAC2 in the first place. She showed that amyloid beta and oxidative stress -- both risk factors for Alzheimer's disease -- can activate a protein called the glucocorticoid receptor 1. This receptor, in turn, can switch on the runaway expression of HDAC2.

"The striking thing is that amyloid beta has a very, very acute effect in elevating HDAC2 expression, but then the consequences can be very long term," Tsai says. This mechanism could explain why clinical trials of drugs that clear out amyloid beta in people with Alzheimer's haven't worked very well, she says.

Finally, Tsai's team looked at postmortem brain tissue from people who died of Alzheimer's disease. These samples, like those in mice, had elevated levels of HDAC2 in the hippocampus and entorhinal cortex.

The clinical applications of this work are promising, Tsai says, but it's important not to oversell the findings. "While all the data look very promising in animal models, human studies are a completely different ball game," she says. "We need to do clinical trials to see whether this concept holds up."


Story Source:

The above story is based on materials provided by Howard Hughes Medical Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Johannes Gräff, Damien Rei, Ji-Song Guan, Wen-Yuan Wang, Jinsoo Seo, Krista M. Hennig, Thomas J. F. Nieland, Daniel M. Fass, Patricia F. Kao, Martin Kahn, Susan C. Su, Alireza Samiei, Nadine Joseph, Stephen J. Haggarty, Ivana Delalle, Li-Huei Tsai. An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature, 2012; DOI: 10.1038/nature10849

Cite This Page:

Howard Hughes Medical Institute. "Reawakening neurons: Researchers find an epigenetic culprit in memory decline." ScienceDaily. ScienceDaily, 29 February 2012. <www.sciencedaily.com/releases/2012/02/120229142134.htm>.
Howard Hughes Medical Institute. (2012, February 29). Reawakening neurons: Researchers find an epigenetic culprit in memory decline. ScienceDaily. Retrieved September 19, 2014 from www.sciencedaily.com/releases/2012/02/120229142134.htm
Howard Hughes Medical Institute. "Reawakening neurons: Researchers find an epigenetic culprit in memory decline." ScienceDaily. www.sciencedaily.com/releases/2012/02/120229142134.htm (accessed September 19, 2014).

Share This



More Mind & Brain News

Friday, September 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) — The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Food Addiction Might Be Caused By PTSD

Food Addiction Might Be Caused By PTSD

Newsy (Sep. 18, 2014) — New research shows that women who suffer from PTSD are three times more likely to develop a food addiction. Video provided by Newsy
Powered by NewsLook.com
Corporal Punishment on Decline, Debate Renews

Corporal Punishment on Decline, Debate Renews

AP (Sep. 16, 2014) — Corporal punishment in the United States is on the decline, but there is renewed debate over its use after Minnesota Vikings running back Adrian Peterson was charged with child abuse. (Sept. 16) Video provided by AP
Powered by NewsLook.com
FDA Eyes Skin Shocks Used at Mass. School

FDA Eyes Skin Shocks Used at Mass. School

AP (Sep. 15, 2014) — The FDA is considering whether to ban devices used by the Judge Rotenberg Educational Center in Canton, Massachusetts, the only place in the country known to use electrical skin shocks as aversive conditioning for aggressive patients. (Sept. 15) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

More Coverage


Reversing Alzheimer's Gene 'blockade' Can Restore Memory, Other Cognitive Functions

Feb. 29, 2012 — Neuroscientists have shown that an enzyme overproduced in the brains of Alzheimer's patients creates a blockade that shuts off genes necessary to form new memories. Furthermore, by inhibiting ... read more
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins